GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $57,773,000 | +15.4% | 1,327,193 | +15.5% | 0.02% | +41.2% |
Q1 2022 | $50,066,000 | -2.2% | 1,149,341 | -1.0% | 0.02% | +13.3% |
Q4 2021 | $51,203,000 | -81.7% | 1,161,052 | -84.2% | 0.02% | -83.0% |
Q3 2021 | $280,114,000 | -6.3% | 7,330,940 | -2.3% | 0.09% | -9.3% |
Q2 2021 | $298,840,000 | -0.4% | 7,504,766 | -10.7% | 0.10% | -3.0% |
Q1 2021 | $299,935,000 | +490.7% | 8,403,880 | +509.1% | 0.10% | +488.2% |
Q4 2020 | $50,774,000 | -3.1% | 1,379,739 | -0.9% | 0.02% | -15.0% |
Q3 2020 | $52,388,000 | -13.5% | 1,391,833 | -6.3% | 0.02% | -23.1% |
Q2 2020 | $60,581,000 | +3.5% | 1,485,193 | -3.9% | 0.03% | -7.1% |
Q1 2020 | $58,544,000 | -12.0% | 1,545,074 | +9.2% | 0.03% | +21.7% |
Q4 2019 | $66,491,000 | +10.6% | 1,415,002 | +0.5% | 0.02% | 0.0% |
Q3 2019 | $60,102,000 | +21.8% | 1,408,203 | +14.2% | 0.02% | +21.1% |
Q2 2019 | $49,356,000 | -10.2% | 1,233,288 | -6.2% | 0.02% | -17.4% |
Q1 2019 | $54,946,000 | +0.9% | 1,314,796 | -7.8% | 0.02% | -8.0% |
Q4 2018 | $54,471,000 | -8.6% | 1,425,578 | -3.9% | 0.02% | +4.2% |
Q3 2018 | $59,578,000 | +0.6% | 1,483,163 | +1.0% | 0.02% | -7.7% |
Q2 2018 | $59,196,000 | -3.5% | 1,468,495 | -6.5% | 0.03% | 0.0% |
Q1 2018 | $61,356,000 | +20.4% | 1,570,412 | +9.3% | 0.03% | +23.8% |
Q4 2017 | $50,953,000 | -17.4% | 1,436,497 | -5.5% | 0.02% | -27.6% |
Q3 2017 | $61,690,000 | -34.6% | 1,519,467 | -30.5% | 0.03% | -40.8% |
Q2 2017 | $94,334,000 | +3.9% | 2,187,696 | +1.5% | 0.05% | -2.0% |
Q1 2017 | $90,828,000 | +13.8% | 2,154,351 | +4.0% | 0.05% | +13.6% |
Q4 2016 | $79,798,000 | -18.9% | 2,072,135 | -9.2% | 0.04% | -25.4% |
Q3 2016 | $98,391,000 | +5.2% | 2,281,271 | +5.7% | 0.06% | 0.0% |
Q2 2016 | $93,548,000 | +14.2% | 2,158,477 | +6.8% | 0.06% | +7.3% |
Q1 2016 | $81,930,000 | -2.7% | 2,020,465 | -3.2% | 0.06% | +1.9% |
Q4 2015 | $84,234,000 | +1.3% | 2,087,574 | -3.4% | 0.05% | -8.5% |
Q3 2015 | $83,134,000 | -19.6% | 2,162,128 | -12.9% | 0.06% | -14.5% |
Q2 2015 | $103,435,000 | -4.5% | 2,483,457 | +5.9% | 0.07% | -6.8% |
Q1 2015 | $108,277,000 | +41.1% | 2,346,200 | +30.7% | 0.07% | +39.6% |
Q4 2014 | $76,728,000 | – | 1,795,236 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |